Joint Computational-Experimental Discovery of novel HAC6 inhibitors for treating triple-negative breast cancer (TNBC)

Project Details

StatusFinished
Effective start/end date2/15/24 → 2/14/25

Funding

  • New Jersey Health Foundation, Inc. (NJHF): $50,000.00